top of page
Esta página web se diseñó con la plataforma
.com
. Crea tu página web hoy.Comienza ya

CONFERENCISTAS

Dr. Ana Luisa Piña-Hernández 

Líder de grupo en Neurociencias en la sección de Neurocirugía Experimental del Departamento de Neurocirugía de la Universidad Médica, Charité, en Berlín.

​

Topics of research

Factores de Crecimiento Angiogenico y Anti-angiogenico  durante el desarrollo, envejecimiento y patogénesis del Sistema Nerviosos Central, con enfoque en los efectos neuroprotectores post-lesión en 

  • Barrera Hematoencefálica 

  • Inflamación

  • Neurogénesis

Dr. Héctor A. Cabrera-Fuentes 

Jefe de la red de laboratorios de investigación en Cardioprotección Kazan-Giessen-Singapur. Adscrito a Duke-NUS, al Instituto Nacional de Cardiología en Singapur y a la Facultad de Medicina de la Universidad de Giessen Alemania.

​

Topics of research

Enfermedades Cardiovasculares 

  • ​

Dr. Rafael Gutiérrez-Aguilar

​Prof. Rafael Gutiérrez obtained his PhD in Neurosciences from the National University of Mexico in 1993. In that year, he was awarded with the prestigious Alexander von Humboldt Research Scholarship and spent 3 years working with Prof. Uwe Heinemann in the University of Cologne and Humboldt University in Berlin. In 1997, he established his laboratory at the National Institute of Psychiatry, where he was the head of the department of Neurophysiology. In 1998 he obtained his tenure at the Center for Research and Advanced Studies in Mexico, where he is full professor at the Department of Pharmacobiology.

He is known in his field for having discovered the co-release of glutamate and GABA from single cells and for the description of mixed electrical-chemical communication between principal neurons of the hippocampus.

​

Topics of research

​

  • Synaptic transmission and its plasticity.  

  • How neural cells work in concert to create activity patterns.

Profr. Dr. Ulrich Dirnagl

At the Charité Universitätsmedizin Berlin Ulrich Dirnagl serves as Director of the Department of Experimental Neurology. Since 2017 he is also the founding director of the Center for Transforming Biomedical Research (CTBR) at the Berlin Institute of Health. CTBR aims at overcoming the roadblocks in translational medicine by increasing the value and impact of biomedical research through maximizing the quality, reproducibility, generalizability, and validity of research.

​

Topics of research

  • Stroke, cerebral blood flow regulation, and brain imaging.

  • Mechanisms by which brain ischemia leads to cell death, and develops novel methods to intercept mechanisms of damage in acute brain damage, as well as to foster regeneration and repair of the lesions.

  • Endogenous neuroprotection and how the brain interacts with other systems of the body after it has been injured.

  • The coupling of regional blood flow to neuronal activity, the mechanism underlying functional brain imaging with MR and PET

​

Profr. Manuel Mayr M.D. PhD.

Manuel Mayr qualified in Medicine from the University of Innsbruck (Austria) in 1999.  In 2001, he moved to London to undertake a PhD, on the topic of “Cardiovascular Proteomics: Linking Proteomic and Metabolomic Changes”. He obtained a British Heart Foundation (BHF) Intermediate Research Fellowship in 2005 and was appointed as Lecturer at King’s College London in 2006. In 2008, he was successful in obtaining a BHF Senior Research Fellowship and this was recently renewed for a second term. In parallel, he achieved promotion to Professor in 2011. His academic achievements have been recognised by the inaugural Michael Davies Early Career Award of the British Cardiovascular Society (2007), the inaugural Bernard and Joan Marshall Research Excellence Prize of the British Society for Cardiovascular Research (2010), and the Outstanding Achievement Award by the European Society of Cardiology Council for Basic Cardiovascular Science (2013). In 2017, he was awarded a BHF Personal Chair.

​

Topics of research

​

  • Vascular proteomics and metabolomics

​

Profr. Dr. Klaus T. Preissner

Prof. Klaus T. Preissner studied Chemistry/Biochemistry in Cologne (Germany) and there he received his PhD in 1978 for research on HDL-structure. He was a postdoctoral fellow at the Department of Immuno-logy at the Scripps Clinic and Research Foundation, La Jolla, CA (1980-1983), investigating regulatory mechanisms of complement attack. Thereafter, he became a principal group leader at the “Clinical Re-search Unit for Blood Coagulation and Thrombosis” of the Max-Planck-Society in Giessen (1983-1997), followed by the position as associate professor in 1987 (Justus-Liebig-University, JLU, Giessen). Since 1998 he is Professor for Biochemistry and Pathobiochemistry at the Depart. Biochemistry, JLU-Medical School in Giessen.

​

Topics of research

  • ​Cell adhesion and proteolytic mechanisms in the context of vascular diseases and wound healing, particularly involving vitronectin and its receptors.

  • His current scientific activities are concerned with innate immunity and alarm mechanisms in cardio-vascular and thrombotic pathologies, particularly with respect to the role of self-extracellular nucleic acids and new therapeutic concepts using endo-nucleases as cardio-protective drugs

​

Dr. Alvaro Rendon. PhD.

He graduated as a Biologist at the Faculty of Sciences, UNAM in May 1966. In the Faculty of Sciences of the University Louis Pasteur of Strasbourg, he obtained the "Doctorat d'Etat". In October,1969, by opposition he got a permanent position at the Centre National de la Recherche Scientifique (CNRS), France where he carried out his entire career until August 30, 2010, the year in which he retired.

He is currently Directeur de Recherche Emérite at the Institute of Vision in Paris. He was a founding member in Strasbourg in 1995 of the Laboratory of Cellular and Molecular Retinal Pathophysiology, a laboratory of translational research on the mechanisms of retinal cell degeneration.

This laboratory was the heart of the current Institute of Vision (Director José-Alain Sahel), which was founded in Paris in 2008.


​

Topics of research

​

  • Role of dystrophins in the development

  • Physiology and vascular pathology of the visual system

​

PD Dr. Dr. Elisa A. Liehn

Head of Cardiovascular Research Group HeART

Department of Cardiology and Angiology, University Hospital Aachen

Institute for Molecular Cardiovascular Research (IMCAR)

IZKFAachen University Hospital.

​

Elisa Liehn, MD, PhD, scientist in cardiovascular research. Her scientific interest focuses on the field of cardiovascular medicine. Using broad experimental and clinical approaches, as well as wide interdisciplinary connections, her team is involved in finding and developing new therapeutical strategies for prevention and treatment of cardiovascular diseases.


​

Topics of research

  • inflammatory processes and extracellular matrix formation after myocardial infarction

  • cardiovascular regenerative and reconstruction therapies

 Dr. Oscar Pérez-Méndez. PhD

Dr. Pérez-Méndez obtained his Ph.D. degree in the Université de Lille II, France with the thesis performed in the Institut Pasteur de Lille. He demonstrated that deep hypoalphalipoproteinemias have their kinetic etiology on an accelerated HDL-apoAI catabolism. Under such circumstances, very low levels of HDL are not associated with increased risk of atherosclerosis. During his postdoctoral fellowship in the Ghent University, Belgium, he demonstrated that some domains of enzymes and lipoprotein remodeling proteins are involved lipid mixing and membrane fusion using fluorescent markers. 


​

Topics of research

​

  • Triglyceride-rich small HDL are associated to coronary clinical events.

  • Sphyngomyelin in HDL subclasses increases when coronary risk factors decreased by weight loss.

  • Impaired HDL lipid remodeling is observed during postprandial period in patients with high risk of atherosclerosis

 Dr. Arturo Reyes-Sandoval. PhD

Dr. Arturo Reyes-Sandoval is an Associate Professor at the Nuffield Department of Medicine (NDM) in the University of Oxford. He is a Principal Investigator at the Jenner Institute. Arturo is currently leading a group working on a research program to develop vaccines for 5 neglected and emerging infectious diseases, including two in pre-clinical phase: Chagas disease and Dengue; and three that have entered clinical stage: P. vivax malaria, Zika and Chikungunya.


​

Topics of research

​

  • P. vivax malaria, Zika and Chikungunya.

  • Chagas disease and Dengue

 PD.Dr. rer nat. Guillermo Barreto

Guillermo Barreto, PD, Dr rer nat, molecular biologist. His research activities are centred on the epigenetic mechanisms that regulate the determination of the respiratory cell fate in the primitive foregut, leading to the formation of the lung bud and later on to the cellular diversity generated in the developing lung. His research group particularly focuses on the mechanisms involved during embryonic lung development that are recapitulated in several lung diseases, such as lung cancer (LC), idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). New experimental approaches, especially those based on studies of embryonic development, are needed to elucidate the molecular mechanisms responsible for these lung diseases.


​

Topics of research

​

  • Chromatin-mediated genome regulation

  • Epigenetic deregulation into the development of diagnostic and therapeutic strategies using molecular targets

 Lutz Steiner.

Cerca de 10 prestigiosos científicos líderes en su área de investigación.

Dr. Ana Luisa Pina-Hernández 

1
2
3
4
5
6
7
8

 Dr. Arturo Reyes-Sandoval. PhD

A seasoned higher education and research manager, Lutz Steiner has been coordinating the International Graduate Program Medical Neurosciences since 2001. This research driven Master and PhD program is run by Charité – Universitätsmedizin Berlin in cooperation with the Humboldt and Freie University as well as the Max-Delbrück-Center for Molecular Medicine, the Berlin Institute of Health, the Leibniz Center for Molecular Pharmacology and the Max-Planck-Institute for Human Development. Lutz Steiner has conceptualized graduate education for the Berlin School of Mind and Brain and NeuroCure, both funded through the excellence initiative, as well as for the Center for Stroke Research Berlin. He managed an EU funded Early Stage Training (FP6) and currently represents Medical Neurosciences in the Erasmus Mundus Joint Master’s Degree Neurasmus.

At Charité, he is an active member of the internal working groups on Master programs, accreditation and internationalization.

​

bottom of page